---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-009606"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T09:55:48.562250+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech appoints Nancy Bryan to Board effective March 28, 2023

## Summary
- Nancy Bryan appointed to Board of Directors effective March 28, 2023; also named to Audit, Corporate Governance and Nomination, and Executive Committees.
- Bryan is President and CEO of BioFlorida with 25 years of life sciences experience including roles at Merck, GlaxoSmithKline, and Bayer.
- Board determined Bryan meets independence standards; she has no material interest in any related-party transactions.
- Bryan's appointment adds commercial and marketing expertise as AIM advances Ampligen toward late-stage development.

## SEC filing metadata
- accession: 0001493152-23-009606
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/0001493152-23-009606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/fom8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-009606
- JSON: https://secwatch.observer/filing/0001493152-23-009606.json
- Plain text: https://secwatch.observer/filing/0001493152-23-009606.txt

## Key facts
- Executive change
  Nancy Bryan was appointed as Director at AIM ImmunoTech Inc..
  - Action: appointed
  - Role: Director
  source text: On March 30, 2023, AIM ImmunoTech Inc. (the “Company”) issued a press release announcing the appointment of Nancy Bryan to its Board of Directors (the “Board”), effective March 28, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/0001493152-23-009606-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.